go-v.orgdoi

C1-Inhibitor substitution as ultima ratio therapy in septic shock: experience with 15 patients

B Vangerow, Gernot Marx, Martin Leuwer, Horst Rueckoldt · Critical Care · 1998

  • DOI 10.1186/cc149
  • Publisher BioMed Central
  • Type conference-abstract
  • Issued 1998

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Critical Care · BioMed Central · conference-abstract · 1998

Abstract

Plasma C1-Inhibitor (C1-INH) is the major inhibitor of both the classical pathway of complement system and contact activation. A relative deficiency of C1-INH has been proposed as an important contributor to the development of shock and organ failure [ 1 , 2 ]. Among others, our working group has published two cases of successful C1-INH substitution in septic patients recently [ 3 ].

Open the resolved locator · 10.1186/cc149

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 03:29 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://link.springer.com/article/10.1186/cc149
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.